Notification No. 12/2021
Date: September 30, 2021
Subject: Temporary concessional/exempt GST rates on COVID-19 related medicines.
Description:
This notification grants Nil or 2.5% CGST on specified COVID-19 medicines such as Tocilizumab, Amphotericin-B, Remdesivir, Favipiravir, 2-Deoxy-D-Glucose, etc. The concession is time-bound and aimed at reducing treatment cost during the pandemic.
Issued for earlier notification?
No — this is a standalone temporary relief notification.
Other Notifications
18/2020
Issued under section 25(6B) of the CGST Act, this notification notifies 01 April...
Read More75/2019
This notification amends Rule 36(4) by reducing provisional ITC from 20% to 10% ...
Read More68/2019
Inserts sub-rules (4), (5) and (6) in Rule 48 of the CGST Rules to mandate prepa...
Read More